Matteo Pardini

Metabolic brain networks in dementia with Lewy bodies: from prodromal to manifest disease stages.

MRI susceptibility map weighted imaging (SMWI) as a neurodegeneration biomarker in the prodromal to overt alpha-synucleinopathy continuum.

Plasma extracellular vesicles and phosphorylated tau 181 as early biomarkers of cognitive impairment in Alzheimer's dementia.

Spontaneous and Drug-Induced Amyloid-Related Imaging Abnormalities: Overlaps, Divergences, and Clinical Implications Across a Continuum Between Alzheimer's Disease and Cerebral Amyloid Angiopathy.

Heterogeneity of dementia with lewy bodies: Insights from clinical presentations, neuropathology, and biomarkers.

Associations of lifestyle factors with amyloid pathology in persons without dementia.